Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Encapsulation on Efavirenz Pharmacokinetics
NCT01087814Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Feb 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by University of Minnesota. Started Feb 2010; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01087814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087814.